We are live on ! Find out more
DH icon

Definitive Healthcare

1.20 USD
-0.01
0.83%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
1.22
+0.02
1.67%
1 day
-0.83%
5 days
-9.77%
1 month
6.19%
3 months
64.95%
6 months
39.65%
Year to date
-49.58%
1 year
-53.85%
5 years
-96.08%
10 years
-97.23%
 

About: Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Employees: 686

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 14.3%
Neutral 85.7%
Negative 0%
Neutral
GlobeNewsWire
4 days ago
Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform
Definitive Healthcare shares early-adopter findings for new AI-powered growth intelligence platform used to power critical healthcare decisions and commercial progress Definitive Healthcare shares early-adopter findings for new AI-powered growth intelligence platform used to power critical healthcare decisions and commercial progress
Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform
Positive
Zacks Investment Research
14 days ago
Definitive Healthcare Corp. (DH) Tops Q3 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
Definitive Healthcare Corp. (DH) Tops Q3 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
15 days ago
Definitive Healthcare Reports Financial Results for Third Quarter 2026
FRAMINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended September 30, 2026.
Definitive Healthcare Reports Financial Results for Third Quarter 2026
Neutral
GlobeNewsWire
16 days ago
Definitive Healthcare announces executive appointments to bolster AI-powered initiatives across the company
Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer Healthcare Data and Analytics Organization Hires Head of AI and Promotes New Chief Product Officer
Definitive Healthcare announces executive appointments to bolster AI-powered initiatives across the company
Neutral
GlobeNewsWire
1 month ago
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
Neutral
GlobeNewsWire
2 months ago
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company's Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company's founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
Neutral
GlobeNewsWire
2 months ago
Definitive Healthcare Appoints Clay Ritchey as CEO
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.
Definitive Healthcare Appoints Clay Ritchey as CEO
Neutral
Seeking Alpha
3 months ago
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
3 months ago
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
Positive
MarketBeat
3 months ago
Definitive Healthcare Q2 Earnings Call Highlights
Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to growth.
Definitive Healthcare Q2 Earnings Call Highlights
Price charts implemented using Lightweight Charts™